2m 2m 2m 2m 2m 2m 2m
TANGO THERAPETCS (TNGX)
NASDAQ
$27.77+$0.79 (+2.92%)
Price as of Oct 22, 2026 7:30 PM EDT- $4.5BMarket Cap
- 211.55%1-Year Change
- BiotechnologyIndustry
TANGO THERAPETCS (TNGX)
$27.77+$0.79 (+2.92%)
TNGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.98 | ||
Change | +$1.73 (+6.85%) | ||
Open | $25.55 | ||
High | $27.60 | ||
Low | $25.35 | ||
Previous Close | $25.25 | ||
Volume | 5,558,512 | ||
30-Day Average Volume | 3,814,839 | ||
1-Week Change | 21.59% | ||
1-Month Change | 20.82% | ||
1-Year Change | 211.55% | ||
3-Year Change | 257.82% | ||
5-Year Change | 107.22% | ||
Fundamentals | |||
Shares Outstanding | 168.6M | ||
Total Assets | $1.1B | ||
Market Cap | $4.5B | ||
Enterprise Value | $4.2B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$55.3M | ||
Free Cash Flow | -$38.8M | ||
EBIT | -$55.3M | ||
EBITDA | -$54.9M | ||
Net Working Capital | $1.0B | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -77 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -73 | ||
PEG | 5 | ||
Price/Free Cash Flow | -117 | ||
Price/Operating Cash Flow | -117 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue